박진현
#간담췌암#기타 암#대장암#비뇨기암#식도암#위암#유방암#피부암
|
학력
서울대학교 의과대학 학사(1999.03 ~ 2005.02)
서울대학교 의과대학 석사(2009.09 ~ 2011.08)
서울대학교 의과대학 박사(2011.09 ~ 2013.08)
서울대학교 의과대학 석사(2009.09 ~ 2011.08)
서울대학교 의과대학 박사(2011.09 ~ 2013.08)
경력
서울대학교 병원 인턴(2005 ~ 2006)
서울대학교 병원 내과 전공의(2006 ~ 2009)
서울대학교 병원 혈액종양내과 전임의(2010 ~ 2011)
서울대학교병원 조교수
서울대학교 병원 내과 전공의(2006 ~ 2009)
서울대학교 병원 혈액종양내과 전임의(2010 ~ 2011)
서울대학교병원 조교수
논문
Park JH, Kim YJ, Lee JO, Lee KW, Kim JH, Bang SM, Chung JH, Kim JS, Lee JS Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era Lung cancer 2011
Park JH, Han SW, Oh DY, Im SA, Jeong SY, Park KJ, Kim TY, Bang YJ Analysis of KRAS, BRAF, PTEN, IGF1R, EGFR intron 1 CA status in both primary tumors and paired metastases in determining benefit from cetuximab therapy in colon cancer Cancer Chemother Pharmacol. 2011
Park JH, Kwon JH, Kim JW, Cho HJ, Kim KH, Chung DH, Kim I, Yoon SS, Park S, Kim BK Generalized Primary Amyloid Lymphadenopathy Korean J Hematol 2009
Han HS, Kim JS, Park JH, Jeon YK, Lee KW, Oh DY, Kim JH, Park SY, Im SA, Kim TY, Park IA, Bang YJ Weekly paclitaxel and trastuzumab as a first-line therapy in patients with HER2-overexpressing metastatic breast cancer: magnitude of HER2/neu amplification as a predictive factor for efficacy. J Korean Med Sci 2009
Kim JW, Park JH, Cho HJ, Kwon JH, Koh Y, Kim SJ, Kim SH, Lee SH, Im SA, Kim YT, Kim WH. A case of desmoplastic small round cell tumor diagnosed in a young female patient Cancer Res Treat 2009
Kwon JH, Kim JW, Park JH, Koh YI, Kim JH, Bang SM, Song JH, Lee JS Long-term Complete Remission in a 71-year-old Patient with AML-M7 after Low-dose Cytarabine Induction and Intermediate-dose Cytarabine Consolidation Treatment. Korean J Hematol 2009
JH Park, SH Lee, B.Keam, TM Kim, DW Kim, SC Yang, YW Kim, DS Heo EGFR mutation as a predictive marker of cytotoxic chemotherapy Lung cancer 2012
JH Park, TM Kim, B.Keam, YK Jeon, SH Lee, DW Kim, DH Chung, YT Kim, YW Kim, DS Heo Tumor burden is predictive of survival in patients with non-small cell lung cancer and with activating epidermal growth factor receptor mutations who receive gefitinib Clinical lung cancer 2013
JH Park, TY Kim, KH Lee, SW Han, DY Oh, SA Im, GH Kang, EK Chie, SW Ha, SY Jeong, KJ Park, JG Park, TY Kim The beneficial effect of pallaitive resection in metastatic colorectal cancer British journal of cancer 2013
B.Keam, DW Kim, JH Park, JO Lee, SH Lee, DH Chung, DS Heo Rare and complex mutations of epidermal growth factor receptor, and efficacy of tyrosine kinase inhibitor in patients with non-small cell lung cancer International journal of clinical oncology 2013
B.Keam, DW Kim, JH Park, JO Lee, SH Lee, DH Chung, DS Heo How molecular understanding affects to prescribing patterns and clinical outcome of gefitinib in non-small cell lung cancer? 10 year experience of single institution Cancer Research and Treatment 2013
Park JH, Han SW, Oh DY, Im SA, Jeong SY, Park KJ, Kim TY, Bang YJ Analysis of KRAS, BRAF, PTEN, IGF1R, EGFR intron 1 CA status in both primary tumors and paired metastases in determining benefit from cetuximab therapy in colon cancer Cancer Chemother Pharmacol. 2011
Park JH, Kwon JH, Kim JW, Cho HJ, Kim KH, Chung DH, Kim I, Yoon SS, Park S, Kim BK Generalized Primary Amyloid Lymphadenopathy Korean J Hematol 2009
Han HS, Kim JS, Park JH, Jeon YK, Lee KW, Oh DY, Kim JH, Park SY, Im SA, Kim TY, Park IA, Bang YJ Weekly paclitaxel and trastuzumab as a first-line therapy in patients with HER2-overexpressing metastatic breast cancer: magnitude of HER2/neu amplification as a predictive factor for efficacy. J Korean Med Sci 2009
Kim JW, Park JH, Cho HJ, Kwon JH, Koh Y, Kim SJ, Kim SH, Lee SH, Im SA, Kim YT, Kim WH. A case of desmoplastic small round cell tumor diagnosed in a young female patient Cancer Res Treat 2009
Kwon JH, Kim JW, Park JH, Koh YI, Kim JH, Bang SM, Song JH, Lee JS Long-term Complete Remission in a 71-year-old Patient with AML-M7 after Low-dose Cytarabine Induction and Intermediate-dose Cytarabine Consolidation Treatment. Korean J Hematol 2009
JH Park, SH Lee, B.Keam, TM Kim, DW Kim, SC Yang, YW Kim, DS Heo EGFR mutation as a predictive marker of cytotoxic chemotherapy Lung cancer 2012
JH Park, TM Kim, B.Keam, YK Jeon, SH Lee, DW Kim, DH Chung, YT Kim, YW Kim, DS Heo Tumor burden is predictive of survival in patients with non-small cell lung cancer and with activating epidermal growth factor receptor mutations who receive gefitinib Clinical lung cancer 2013
JH Park, TY Kim, KH Lee, SW Han, DY Oh, SA Im, GH Kang, EK Chie, SW Ha, SY Jeong, KJ Park, JG Park, TY Kim The beneficial effect of pallaitive resection in metastatic colorectal cancer British journal of cancer 2013
B.Keam, DW Kim, JH Park, JO Lee, SH Lee, DH Chung, DS Heo Rare and complex mutations of epidermal growth factor receptor, and efficacy of tyrosine kinase inhibitor in patients with non-small cell lung cancer International journal of clinical oncology 2013
B.Keam, DW Kim, JH Park, JO Lee, SH Lee, DH Chung, DS Heo How molecular understanding affects to prescribing patterns and clinical outcome of gefitinib in non-small cell lung cancer? 10 year experience of single institution Cancer Research and Treatment 2013
저서
저서 내용이 없습니다.
보도자료
보도자료 내용이 없습니다.
포스팅
포스팅 내용이 없습니다.
영상자료
영상자료 내용이 없습니다.
발표자료
발표자료 내용이 없습니다.